CHARLOTTE MATSCHEK: Open Payments
NPI 1881106839 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 38 payments from 10 companies in 2025. Trend: 2023 $280 · 2024 $339 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $149 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| ABBVIE INC. | 3 | $53 |
| Novo Nordisk Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: OTEZLA, QULIPTA, FARXIGA, INSPIRE, GEMTESA, JARDIANCE, PROCLAIM, REPATHA.
Industry payments across TX — which companies pay providers there.
